Rupali Chaitanya Mahida, NP

Rupali Mahida practices at Stanislaus Surgical Hospital in Modesto, California, part of Physicians Surgery Centers.

Rupali Mahida's NPI, 1245823822, was assigned on February 16, 2021. Rupali Mahida holds California license 95016695.

Rupali Mahida's primary practice is Stanislaus Surgical Hospital, at 1421 Oakdale Road, Modesto, CA 95355 in Stanislaus County. The practice phone is (209) 572-2700.

Rupali Mahida's primary practice is Stanislaus Surgical Hospital in Modesto, California, part of Physicians Surgery Centers. The medical group on file is Family First Medical Care. Dmand AI also links Rupali Mahida to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rupali Mahida practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Rupali Mahida's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Rupali Mahida is licensed in California.

CMS data shows 39 Medicare services from Rupali Mahida across 1 procedure code in 2024, all of them office visits, for 37 Medicare patients. Medicare paid $1,025 for them. Every service was in an office.

CMS counts 37 Medicare patients who saw Rupali Mahida in 2024. The largest group is 65 to 74, with 17 patients. 68% of them have high blood pressure, and 65% have high cholesterol. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Rupali Mahida's median patient age at 45, with 71% women.

In 2024, Rupali Mahida wrote 1,394 Medicare Part D claims for 212 patients. 84% of them were for generic drugs. CMS names the drug for 1,001 of them, across 39 drugs with 11 or more claims each, at $83,084 in total drug cost.

Rupali Mahida accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rupali Mahida as offering telehealth.

CMS Open Payments shows 5 general payments to Rupali Mahida from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Hologic Inc paid the most, $48.